Skip to main content

Find Clinical Trials

Home
Conditions
SMARCB1-deficient Renal Medullary Carcinoma

Clinical trial condition

SMARCB1-deficient Renal Medullary Carcinoma

Explore clinical trials studying SMARCB1-deficient Renal Medullary Carcinoma. Study availability and eligibility vary by location and protocol.

1 public trial 0 recruiting studies

Refine in advanced search Browse all conditions

SMARCB1-deficient Renal Medullary Carcinoma trial results

Not Yet Recruiting

Phase II Trial of Sacituzumab Tirumotecan in Patients With SMARCB1-Deficient Renal Medullary Carcinoma

NCT07438626

Conditions: Phase II, SMARCB1-deficient Renal Medullary Carcinoma, Sacituzumab, +1 more
Locations: MD Anderson Cancer Center Houston, Texas, United States

View Trial Details